OPRX - OptimizeRx Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
15.11
-0.42 (-2.70%)
At close: 4:00PM EDT

15.11 0.00 (0.00%)
After hours: 4:53PM EDT

Stock chart is not supported by your current browser
Previous Close15.53
Open15.53
Bid15.01 x 1100
Ask15.18 x 1300
Day's Range15.00 - 15.69
52 Week Range8.92 - 18.39
Volume36,369
Avg. Volume120,929
Market Cap185.533M
Beta (3Y Monthly)0.14
PE Ratio (TTM)431.71
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire24 days ago

    OptimizeRx Set to Join Russell Microcap® and 3000® Indexes

    OptimizeRx Corp.  (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, is expected to join the Russell Microcap® and 3000® Indexes at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the U.S. market opens on July 1, according to a preliminary list of additions posted June 21. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “We are honored to be included in the Russell Indexes,” said OptimizeRx CEO, William Febbo.

  • GlobeNewswirelast month

    OptimizeRx to Participate at the 5th Annual ROTH London Conference on June 17-19, 2019

    OptimizeRx Corp. (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has been invited to participate in the ROTH London Conference being held on June 17-19, 2019 at the Dorchester Hotel in London, U.K. The ROTH London Conference will give investors extensive interaction and one-on-one/small group meetings with management teams from about 50 small/mid-cap companies in the technology, cleantech and industrial sectors, and provide in-depth insights into each of them.

  • GlobeNewswirelast month

    OptimizeRx Launches New Growth Phase Immediately Following Addition of Chief Commercial Officer

    OptimizeRx Corp. (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has added three senior sales executives to its rapidly growing commercial team. The new hires demonstrate the company’s focus on driving growth and expanding its enterprise-level offerings. “Todd, Eze and Adam are each proven commercial sales leaders with strong records of delivering enterprise-level solutions and addressing unmet needs across the care continuum,” said Steve Silvestro, the company’s recently added chief commercial officer. According to a recent PWC study, 52 percent of consumers with a high deductible health plan say it would be hard to meet their deductible.

  • GlobeNewswirelast month

    OptimizeRx Announces Pricing of Public Offering of Common Stock

    OptimizeRx Corporation (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering of 1,538,500 shares of its common stock, at a public offering price of $13.00 per share. The gross proceeds to OptimizeRx from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by OptimizeRx, are expected to be approximately $20.0 million.  In connection with the offering, OptimizeRx granted the underwriters a 30-day option to purchase up to an additional 230,775 shares of its common stock at the public offering price, less the underwriting discount and commissions.

  • GlobeNewswirelast month

    OptimizeRx Announces Proposed Public Offering of Common Stock

    OptimizeRx Corporation (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced a proposed underwritten public offering of shares of its common stock.  In connection with the offering, OptimizeRx expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering on the same terms and conditions.  All shares to be sold in the offering are to be sold by OptimizeRx.

  • GlobeNewswire2 months ago

    OptimizeRx to Participate at Investor Conferences in June

    ROCHESTER, Mich., May 31, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to.

  • GlobeNewswire2 months ago

    OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $833,000 or $0.06 per Diluted Share

    ROCHESTER, Mich., May 08, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the.

  • ACCESSWIRE2 months ago

    OptimizeRx Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 8, 2019 / OptimizeRx Corp. (NASDAQ: OPRX ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 8, 2019 at 4:30 PM Eastern Time. ...

  • PR Newswire3 months ago

    EVERSANA and OptimizeRx Partner to Deliver High Tech and High Touch Pharmaceutical Services

    Combined offering integrates EHR network and proactive patient services to improve access and adherence LAS VEGAS , April 30, 2019 /PRNewswire/ --  EVERSANA ™, the leading independent provider of global ...

  • GlobeNewswire3 months ago

    OptimizeRx Strengthens Executive Leadership with Appointment of Chief Commercial Officer

    OptimizeRx Corp. (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has appointed Stephen Silvestro to the new position of chief commercial officer. Silvestro will be responsible for driving OptimizeRx’s platform revenue growth, including enterprise level direct-to-patient and direct-to-provider product adoption to improve patient outcomes.

  • GlobeNewswire3 months ago

    OptimizeRx Sets First Quarter 2019 Conference Call for Wednesday, May 8, 2019 at 4:30 p.m. ET

    ROCHESTER, Mich., April 26, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call.

  • GlobeNewswire3 months ago

    OptimizeRx to Present at Investor Conferences in May

    ROCHESTER, Mich., April 23, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at.

  • ACCESSWIRE3 months ago

    MicroCap Review Magazine Spring 2019 Issue Now Available

    The Digital Issue of the Spring 2019 MicroCap Review Magazine,The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / April 23, 2019 / SNN ...

  • GlobeNewswire3 months ago

    OptimizeRx Expands Investment in Hospitals and Health Systems with Latest Tech and Personnel Adds

    OptimizeRx Corp. (OPRX), a leading digital health messaging platform for the pharmaceutical industry, announced its latest platform integration with the health care industry’s leading acute electronic health record (EHR) systems, including Epic and Cerner. This latest announcement is a reflection of the company’s continued investment in hospitals and health systems, also emphasized in the latest company hiring of Denys Ashby as vice president of Hospitals & Health Systems.

  • GlobeNewswire4 months ago

    OptimizeRx Survey Shows Providers Want to Engage with Patients on Drug Costs for Adherence and Improved Care

    OptimizeRx Corp. (OPRX), a leading digital health messaging platform for the pharmaceutical industry , released its full results and findings from its Drug Cost Survey. The cost of prescription drugs is on the mind of physicians and patients alike.

  • GlobeNewswire5 months ago

    OptimizeRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019; Pre-Conference Webcast Available March 11

    OptimizeRx Corp. (OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at the 31st Annual ROTH Conference being held at The Ritz Carlton, Laguna Niguel in Orange County, California, on March 17-19, 2019. Last year, the ROTH Conference hosted close to 550 participating companies and more than 4,700 attendees, including institutional investors, analysts, family offices and high net worth investors. The network has become the largest of its kind, now reaching more than half of the ambulatory patient market in the U.S.

  • GlobeNewswire5 months ago

    OptimizeRx Reports Fourth Quarter 2018 Results; Net Revenue Up 64% to a Record $6.6 Million, Driving First Profitable Year

    ROCHESTER, Mich., Feb. 26, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the.

  • GlobeNewswire5 months ago

    OptimizeRx Sets Fourth Quarter and Full Year 2018 Conference Call for Tuesday, February 26, 2018 at 4:30 p.m. ET

    ROCHESTER, Mich., Feb. 13, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call.

  • GlobeNewswire5 months ago

    OptimizeRx Survey Shows Providers Believe They Have a Role in Discussing Care Costs with Patients

    OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, announced today its initial findings from a physician survey focused on prescription drug costs.

  • GlobeNewswire5 months ago

    OptimizeRx Introduces OptimizeMDs, a “Voice of the Physician” Multi-Specialty Digital Health Panel

    OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has formed OptimizeMDs, a multi-specialty physician panel with the mission of improving the effectiveness of digital health communications delivered throughout the care continuum. “OptimizeRx provides technology designed to streamline and improve communications between pharma/life sciences, providers and patients,” said Miriam Paramore, president of OptimizeRx.

  • GlobeNewswire6 months ago

    OptimizeRx Announces New Partnership with Health IT Pioneer lllumiCare

    OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, announced a new partnership with IllumiCare, a pioneer in point-of-care healthcare information technology that saves hospitals millions annually. IllumiCare's Smart Ribbon® platform will feature a new app from OptimizeRx, the RxSavings App, to present drug savings opportunities—such as co-pay offers and vouchers—that providers and the clinical care team can distribute to the patient directly at the point-of-care.

  • GlobeNewswire8 months ago

    OptimizeRx Joins MSCI USA Microcap Index

    OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, joined the MSCI USA Microcap Index at the conclusion of the MSCI indexes semi-annual reconstitution, effective after the U.S. market closes today, according to the MSCI website. “Joining the MSCI USA Microcap Index represents another major market milestone for OptimizeRx after our up-listing to Nasdaq earlier this year,” said OptimizeRx CEO, William Febbo.

  • ACCESSWIRE8 months ago

    OptimizeRx to Present at 11th Annual LD Micro Main Event on December 4-6, 2018

    ROCHESTER, MI / ACCESSWIRE / November 28, 2018 / OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to present at 11th Annual LD Micro Main Event institutional investor conference being held on December 4-6, 2018 at the Luxe Sunset Bel Air Hotel in Bel Air, California. William Febbo, CEO of OptimizeRx, is scheduled to present on Tuesday, December 4, at 1:30 p.m. Pacific time, with one-on-one meetings with institutional analysts and investors. The presentation will be also webcast live and available for replay here and via the investor relations section of the company's website at www.optimizerx.com.